TNFSF13 and glioma: We have previously reported that APRIL promoted proliferation of glioblastoma-derived cell lines [29] and protected them from CD95- and TRAIL-mediated apoptosis [14], while TWEAK was found to protect glioma cell growth/progression (discussed in [56].